PATH-03. CLINICAL UTILITY OF NEXT GENERATION SEQUENCING IN IDH-WILDTYPE GLIOBLASTOMA: THE DANA-FARBER CANCER INSTITUTE EXPERIENCE

BACKGROUND: Comprehensive next generation sequencing (NGS) is available through many academic institutions and commercial entities, and is incorporated in practice guidelines for glioblastoma (GBM). We retrospective evaluated the practice patterns and utility of incorporating NGS data into routine c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Jane Lim-Fat, Mary, Youssef, Gilbert, Touat, Mehdi, Iorgulescu, Bryan, Woodward, Eleanor, Whorral, Sydney, Allen, Marie, Vogelzang, Jayne, Pisano, William, Rahman, Rifaquat, Chukwueke, Ugonma, Mcfaline-Figueroa, Jose, Nayak, Lakshmi, Lee, Eudocia, Batchelor, Tracy, Chiocca, E Antonio, Meredith, David, Santagata, Sandro, Reardon, David, Beroukhim, Rameen, Bi, Wenya Linda, Ligon, Keith, Wen, Patrick
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Molecular Pathology & Classification
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650887/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.685
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados